Isracann Biosciences Stock Price History
If you're considering investing in Isracann Pink Sheet, it is important to understand the factors that can impact its price. Isracann Biosciences holds Efficiency (Sharpe) Ratio of -0.13, which attests that the entity had a -0.13% return per unit of risk over the last 3 months. Isracann Biosciences exposes zero different technical indicators, which can help you to evaluate volatility embedded in its price movement.
Isracann Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Isracann |
Sharpe Ratio = -0.126
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ISCNF |
Estimated Market Risk
12.6 actual daily | 96 96% of assets are less volatile |
Expected Return
-1.59 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Isracann Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Isracann Biosciences by adding Isracann Biosciences to a well-diversified portfolio.
Isracann Biosciences Pink Sheet Price History Chart
There are several ways to analyze Isracann Stock price data. The simplest method is using a basic Isracann candlestick price chart, which shows Isracann Biosciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 5, 2024 | 1.0E-4 |
Lowest Price | November 21, 2024 | 0.0 |
Isracann Pink Sheet Price History Data
The price series of Isracann Biosciences for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 0.0 with a coefficient of variation of 31.87. Under current investment horizon, the daily prices are spread out with arithmetic mean of 0.0. The median price for the last 90 days is 0.0. The company completed 1:3 stock split on 17th of October 2019. Isracann Biosciences completed dividends distribution on 2019-10-17.Open | High | Low | Close | Volume | ||
11/29/2024 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
11/27/2024 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
11/26/2024 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
11/25/2024 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
11/22/2024 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
11/21/2024 | 0.00 | 0.00 | 0.00 | 0.00 | 74,535 | |
11/20/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
11/19/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
11/18/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
11/15/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
11/14/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
11/13/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
11/12/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
11/11/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
11/08/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 2,600 | |
11/07/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 300.00 | |
11/06/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
11/05/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
11/04/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
11/01/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/31/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/30/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/29/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/28/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/25/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/24/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/23/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/22/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/21/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/18/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/17/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/16/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/15/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/14/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/11/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/10/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/09/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/08/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/07/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/04/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/03/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/02/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
10/01/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/30/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/27/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/26/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/25/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/24/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/23/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/20/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 68,183 | |
09/19/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/18/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/17/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/16/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/13/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/12/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/11/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/10/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/09/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/06/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/05/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
About Isracann Biosciences Pink Sheet history
Isracann Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Isracann is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Isracann Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Isracann Biosciences stock prices may prove useful in developing a viable investing in Isracann Biosciences
Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada. Isracann Biosciences is traded on OTC Exchange in the United States.
Isracann Biosciences Pink Sheet Technical Analysis
Isracann Biosciences technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
All Next | Launch Module |
Complementary Tools for Isracann Pink Sheet analysis
When running Isracann Biosciences' price analysis, check to measure Isracann Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Isracann Biosciences is operating at the current time. Most of Isracann Biosciences' value examination focuses on studying past and present price action to predict the probability of Isracann Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Isracann Biosciences' price. Additionally, you may evaluate how the addition of Isracann Biosciences to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Transaction History View history of all your transactions and understand their impact on performance | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |